Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

For example, while 501 000 women started taking the pills from mid-2023 to mid-2024, less than half that number were still taking the tablets in mid-2024 – keep this in mind when considering the above ...

Eight million people living with HIV. Just over 6 million on treatment. Behind these big numbers lurk a universe of fascinating epidemiological dynamics. In this special briefing, Spotlight editor ...

Accordingly, TB is the top cause of HIV-related deaths in South Africa. Recovering life expectancy Just what a big deal HIV has been in South Africa is clear from estimates of life expectancy in the ...

The cuts will shutter two major HIV vaccine research efforts that were first funded by the NIH in 2012 at the Duke Human Vaccine Institute and the Scripps Research Institute, multiple scientists said.

The Trump administration is reportedly considering eliminating the HIV prevention division that is a part of the CDC in another move that targets government spending and HIV care. 1 Although there ...

How Trump’s foreign aid shutdown affects the world, in three graphs Here’s where U.S. aid goes, what it is for and who is responsible for administering it.

This work is aimed at describing the workflow for a methodology that combines chemoinformatics and pharmacoepidemiology methods and at reporting the first predictive model developed with this ...

Predicting active anti-HIV molecules is a fundamental task in the field of drug development. It drives progress in anti-HIV drug discovery, including aspects such as design, synthesis and activity ...

You can order two HIV self-tests for free, thanks to a CDC-funded program called Together TakeMeHome that launched in 2023.